Right to Try Psilocybin: Law, Death, and Dignity - Kathryn L. Tucker, J.D.
Release Date: 04/27/2026
The Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Mira Funk, LCSW, a Harvard-educated psychotherapist and the founder of , a private practice built around 5-MeO-DMT, N,N-DMT, and salvia divinorum. This episode is sponsored by Mira Funk. Mira traces her path from fourteen years of Zen meditation into psychedelic work, and explains how a severe reaction to a common nootropic supplement unexpectedly reoriented her entire practice toward presence rather than dramatic, otherworldly trips. She and Paul go deep on the extended-release routes she has pioneered, including...
info_outlineThe Psychedelic Podcast
Paul talks with biohacking pioneer Dave Asprey about medicalization, microdosing, consciousness, and Dave's new BEYOND Wonderland psychedelics conference in Austin. In this bonus episode, Paul welcomes back Dave Asprey, founder of Bulletproof Coffee and creator of the biohacking movement, to talk about BEYOND Wonderland, the psychedelics conference Dave has revamped for October 12-14 in Austin. They also get into medicalization, the CIA's documented role in psychedelic history, what responsible microdosing regulation could look like, and why Dave is as focused on unlocking latent human ability...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with computer scientist, climate investor, and Nexus author Ramez Naam about psychedelics, AI, neurotechnology, and cognitive liberty. Find full show notes and links here: Ramez shares how psychedelic experiences sparked his interest in neuroscience, inspired his books, and helped redirect his work toward climate and clean energy. He and Paul explore what brain-computer interfaces can do today, the future of psychedelic mental healthcare, and how to protect freedom of thought as AI becomes a more personal tool. Ramez Naam is a...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with therapist and InnerEthics® founder Kylea Taylor about why responsible psychedelic therapy requires more than good intentions. Find full show notes and links here: Kylea explains why non-ordinary states can amplify intimacy, vulnerability, countertransference, and practitioner blind spots. She presents ethics as an ongoing practice of self-inquiry, restraint, and right relationship rather than a set of rules consulted only after something goes wrong. Paul and Kylea also examine personal experience as preparation for...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Paije Alexandra West, founder of , about iboga, ibogaine, and Bwiti initiation. Drawing on Paul’s recent retreat experience at ETÉREO in Baja, they examine what can be lost when iboga is reduced to a clinical alkaloid and how traditional ceremony can coexist with rigorous medical screening. Paije explains the differences between iboga root bark and total alkaloid extract, the role of Bwiti music, and why discomfort, community, and long-term integration are central to working responsibly with this demanding medicine....
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with psychiatrist and TaperClinic founder Dr. Josef Witt-Doerring about antidepressant withdrawal, psychiatric deprescribing, and psychedelic readiness. Find full show notes and links here: Josef explains what he learned reviewing drug safety at the FDA, why withdrawal can be mistaken for relapse, and how tapering often becomes more difficult at lower doses. They also explore the lifestyle foundations of mental health, benzodiazepine withdrawal, and why psychedelic clinics may need far more sophisticated support as increasingly...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with investigative journalist Robert Whitaker about the evidence behind psychiatric prescribing, SSRI withdrawal, and what psychedelic medicine can learn from that history. Find full show notes and links here: Whitaker revisits the chemical imbalance theory, long-term antidepressant outcomes, and how psychiatric drugs evolved from short-term interventions toward chronic use. He also explores the social and environmental dimensions of mental health before turning to psychedelic medicine and the risks of recreating a...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Remi Drozd back to explore ketamine, SSRIs, and the changing landscape of psychedelic mental health care. Find full show notes and links here: Since Remi first appeared on the podcast in Episode 182, Lucid Therapeutics has grown from a small ketamine practice into a ten-room interventional mental health clinic offering ketamine treatments, Spravato, TMS, therapy, integration support, and other approaches. Paul and Remi examine one of the less-discussed challenges facing psychedelic medicine: many prospective patients are...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Richard Louis Miller about what psychedelic medicine must get right as it moves toward broader acceptance. Richard explains why transparent reporting of adverse effects is essential to informed choice, where research still leaves important gaps, and how commercialization could shape access and treatment. They examine 5-MeO-DMT, group therapy, and the limits of one-to-one care. Richard also shares his approach to aging through exercise, real food, rest, and human connection. Dr. Richard Louis Miller is a clinical...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Ian Gardner, founder and CEO of , about dark retreats as an ancient contemplative practice now entering Western culture. This episode is sponsored by The Acraya. Listeners of The Psychedelic Podcast can receive 5% off an Acraya retreat. Visit and use discount code 3WAVE when booking. Ian explains what happens when external stimulation disappears, why boredom and difficult inner material can become central parts of the experience, and how dark retreats compare with psychedelics and extended meditation. He also discusses...
info_outlineIn this episode of The Psychedelic Podcast, Paul F. Austin speaks with Kathryn L. Tucker, J.D., a leading civil rights attorney and advocate for end-of-life autonomy, about the legal effort to expand access to psilocybin-assisted therapy for patients facing serious illness.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-353/?ref=278
Kathryn shares how decades of work in right-to-die litigation led her to recognize a critical gap in palliative care, addressing psychological and existential suffering at the end of life. Drawing from emerging clinical research, she explains why psilocybin may offer meaningful relief for anxiety, depression, and distress in terminal patients.
The conversation explores the legal pathways being pursued to make this treatment accessible, including Right to Try laws, federal litigation with the DEA, and efforts to reschedule psilocybin. Kathryn also reflects on the broader cultural and ethical implications of allowing individuals greater choice in how they approach death.
Kathryn L. Tucker, JD, is a nationally recognized leader in advancing improved care for seriously ill and dying patients. She has held leadership roles across multiple nonprofit organizations, including the National Psychedelics Association, the End of Life Liberty Project, and Compassion & Choices. Tucker has litigated landmark cases before the U.S. Supreme Court, including Washington v. Glucksberg and Vacco v. Quill, and has played a key role in both end-of-life litigation and psychedelic policy advocacy.
Highlights:
- Right to Try laws explained
- Psilocybin as investigational medicine
- DEA barriers to patient access
- Litigation strategies for psychedelic access
- Rescheduling psilocybin efforts
- Palliative care gaps in mental suffering
- Legal vs underground psychedelic
Episode Links:
Episode Sponsors:
- The Microdosing Practitioner Certification at Psychedelic Coaching Institute.
- The Practitioner Certification Program by Third Wave’s Psychedelic Coaching Institute.
- Golden Rule - Get a lifetime discount of 10% with code THIRDWAVE at checkout
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can’t and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn’t responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.